Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy

December 17, 2021 updated by: Wake Forest University Health Sciences

Presurgical Arm Exercises Prior to Creation of a Forearm AV Fistula in Hemodialysis (HD) Patients With End-stage Kidney Disease: A Pilot Study

For chronic hemodialysis patients, the creation of a well-functioning arteriovenous (AV) fistula is critical for ensuring that patient receive adequate hemodialysis. Unfortunately, the primary failure rate for AV fistulas after surgery is about 40%, and this percentage has not changed despite a number of trials of pharmaceutical agents and biologic agents. A key to success in the development of a useable AV fistula is an adequate arterial and venous diameter in the access forearm. Although exercise is commonly used to increase vessel diameter after AV fistula placement, Investigators are unaware of published studies that report on the effect of exercise prior to AV fistula placement to assist with the maturation of a newly created AV fistula. In this pilot trial, the Principal Investigator will evaluate the feasibility and possible benefits of pre-surgical exercise on forearm AV fistulas.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The trial is designed to determine if a pre-surgical exercise program will improve the likelihood of a useable forearm AV fistula. In this pilot study, the feasibility of the proposed intervention will be assessed in terms of both patient acceptability and patient outcomes. In addition, results from this feasibility study will be used to help determine power calculations for a full-scale trial.

Patients will be eligible for this pilot clinical trial if scheduled for placement of an elective forearm AV fistula for chronic hemodialysis access. Patients will be randomized using a random number generator to either the intervention or the control group. The intervention group will be instructed in the use of hand grip with built in digital counter. These instructions will include the use of the hand grip on a daily basis with an increasing number of hand grip squeezes to be performed each week up until the time of fistula placement.

Patients in the control group will not receive any pre-surgical instructions for exercise in the access arm. In both groups, patients will be provided with post-surgical instructions on the use of a squeeze ball on a daily basis once the steri-strips from the surgical site have fallen off.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest University Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Scheduled for placement of an elective forearm AV fistula for chronic hemodialysis access.

Exclusion Criteria:

  • The presence of joint or musculoskeletal impairments that prevent the patient from using a handgrip device on a daily basis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Exercise
Participant randomized to an exercise protocol using a hand grip device that is used on a daily basis. Participant will be encouraged to increase the number of repetitions used by the hand grip device during the course of the trial
Participant randomized to an exercise protocol using a hand grip device that is used on a daily basis. Participant will be encouraged to increase the number of repetitions used by the hand grip device during the course of the trial
NO_INTERVENTION: Control
Participants in the control group will not receive any pre-surgical instructions for exercise in the access arm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with fistula usable without intervention
Time Frame: Up to 12 weeks after surgical creation of the AV fistula
Fistula usability will be measured by the use of the AV fistula for two needle cannulation for chronic dialysis sessions within 12 weeks after surgical creation.
Up to 12 weeks after surgical creation of the AV fistula
Number of participants with fistula usable with intervention
Time Frame: Up to 12 weeks after surgical creation of the AV fistula
Fistula usability will be measured by the use of the AV fistula for two needle cannulation for chronic dialysis sessions within 12 weeks after surgical creation.
Up to 12 weeks after surgical creation of the AV fistula
Number of participants with fistula not usable
Time Frame: Up to 12 weeks after surgical creation of the AV fistula
Fistula usability will be measured by the use of the AV fistula for two needle cannulation for chronic dialysis sessions within 12 weeks after surgical creation.
Up to 12 weeks after surgical creation of the AV fistula

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Number of hand grips per day
Time Frame: Up to 8 weeks after start of the intervention
Up to 8 weeks after start of the intervention
Mean Number of days hand grips performed
Time Frame: Up to 8 weeks after start of the intervention
Up to 8 weeks after start of the intervention
Total mean number of hand grip repetitions performed
Time Frame: Up to 8 weeks after start of the intervention
Up to 8 weeks after start of the intervention
Cephalic Vein Doppler measurement
Time Frame: Up to 8 weeks after start of the intervention
The diameter of the vessel in centimeters will be measured using a Duplex Doppler.
Up to 8 weeks after start of the intervention
Basilic Vein Doppler measurement
Time Frame: Up to 8 weeks after start of the intervention
The diameter of the vessel in centimeters will be measured using a Duplex Doppler.
Up to 8 weeks after start of the intervention
Median Cubital Doppler measurement
Time Frame: Up to 8 weeks after start of the intervention
The diameter of the vessel in centimeters will be measured using a Duplex Doppler.
Up to 8 weeks after start of the intervention
Radial Artery Doppler measurement
Time Frame: Up to 8 weeks after start of the intervention
The diameter of the vessel in centimeters will be measured using a Duplex Doppler.
Up to 8 weeks after start of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Rocco, MD, MSCE, Wake Forest University Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 17, 2019

Primary Completion (ACTUAL)

September 15, 2021

Study Completion (ACTUAL)

November 9, 2021

Study Registration Dates

First Submitted

June 12, 2019

First Submitted That Met QC Criteria

June 14, 2019

First Posted (ACTUAL)

June 17, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 10, 2022

Last Update Submitted That Met QC Criteria

December 17, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis Access Failure

Clinical Trials on Exercise

3
Subscribe